MedChemBio – collective research (Q11151)

From EU Knowledge Graph
Revision as of 15:35, 28 October 2020 by DG Regio (talk | contribs) (‎Removed claim: financed by (P890): Directorate-General for Regional and Urban Policy (Q8361), Removing unnecessary financed by statement)
Jump to navigation Jump to search
Project Q11151 in Czech Republic
Language Label Description Also known as
English
MedChemBio – collective research
Project Q11151 in Czech Republic

    Statements

    0 references
    9,107,700.0 Czech koruna
    0 references
    364,308.0 Euro
    10 January 2020
    0 references
    13,011,000.0 Czech koruna
    0 references
    520,440.0 Euro
    10 January 2020
    0 references
    70 percent
    0 references
    19 January 2017
    0 references
    31 August 2019
    0 references
    MedChemBio
    0 references
    0 references

    49°35'41.89"N, 17°16'31.12"E
    0 references
    77900
    0 references
    1.podprojekt pomůže ve fázi výroby hodnocených léčiv. přípravků pro moderní terapie(LPMT). Cílem je zajistit kvalitní výsledky pre-validačních a valid. studií, a vyvinout specif. metody kontroly kvality nových produktů pro dokončení vývoje a zahájení výroby LPMT v režimu SVP. Součástí bude i zahájení studie směřující k identifikaci biomarkerů účinnosti LPMT. a. (Czech)
    0 references
    1. subproject will help in the stage of production of evaluated drugs. products for modern therapy (LPMT). The aim is to ensure quality results of pre-validation and valid. studies, and to develop specific methods of quality control of new products to complete development and start production of LPMT in the SVP mode. It will also include the launch of a study aimed at identifying the biomarkers of the efficacy of LPMT. a. (English)
    22 October 2020
    0 references

    Identifiers

    CZ.01.1.02/0.0/0.0/16_079/0008825
    0 references